Organogenesis Holdings Inc.ORGOEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Albert Erani | 17.80% | 22.3M | — | 2024-11-14 |
| Avista Healthcare Partners III, L.P. | 11.60% | 17.3M | — | 2024-11-19 |
| NOS. OF ABOVE PERSONS | 8.90% | 11.8M | ▲ +2.10pp | 2024-11-14 |
Insider Transactions
Net 90d: +$40.1K · buys $40.1K / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-09 | Driscoll Michael Joseph | Director | Buy (open market) | 10.0K | $2.67 | $26.7K |
| 2026-03-09 | Leibowitz Arthur S | Director | Buy (open market) | 5.0K | $2.68 | $13.4K |
| 2026-02-18 | Gillheeney Gary S. | President and CEO | Grant | 188.9K | $0.00 | $0 |
| 2026-02-18 | Montecalvo Antonio S. | Vice President, Health Policy | Grant | 11.3K | $0.00 | $0 |
| 2026-02-18 | David Francisco | Chief Financial Officer | Grant | 44.0K | $0.00 | $0 |
| 2026-02-18 | Brian Grow | Chief Commercial Officer | Grant | 48.8K | $0.00 | $0 |
| 2026-02-18 | Patrick Bilbo | Chief Operating Officer | Grant | 49.1K | $0.00 | $0 |
| 2026-02-18 | Lori Freedman | Chief Admin. and Legal Officer | Grant | 43.2K | $0.00 | $0 |
| 2026-02-18 | Robert Cavorsi | Vice President, Strategy | Grant | 16.5K | $0.00 | $0 |
| 2026-02-18 | Lori Freedman | Chief Admin. and Legal Officer | Grant | 203.1K | $0.00 | $0 |
1–10 of 30
Page 1 / 3